Fabienne Marcellin Selected Research

Fabienne Marcellin Research Topics

8	Hepatitis C 01/2024 - 01/2007
8	Infections 03/2023 - 09/2007
7	Coinfection 04/2020 - 01/2007
6	Fibrosis (Cirrhosis) 01/2024 - 01/2018
5	Chronic Hepatitis C 03/2023 - 01/2008
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 12/2008
4	Liver Diseases (Liver Disease) 01/2023 - 01/2020
4	Opioid-Related Disorders (Opiate Addiction) 10/2019 - 01/2014
3	Fatigue 03/2023 - 09/2007
3	Alcoholism (Alcohol Abuse) 01/2023 - 09/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 01/2018
3	Chronic Hepatitis B 02/2022 - 11/2021
2	Substance-Related Disorders (Drug Abuse) 11/2023 - 09/2014
2	Fatty Liver 01/2021 - 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2024
1	Multiple Sclerosis 09/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Hypertension (High Blood Pressure) 02/2022
1	Dyslipidemias (Dyslipidemia) 02/2022
1	Hepatitis B 01/2022
1	COVID-19 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Persistent Infection 09/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2016
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2016
1	HIV Infections (HIV Infection) 03/2013

11	Antiviral Agents (Antivirals)IBA 11/2023 - 03/2017
5	Coffee FDA Link 06/2022 - 01/2018
5	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2014
4	Methadone (Dolophine)FDA LinkGeneric 09/2014 - 01/2014
3	CannabinoidsIBA 09/2023 - 01/2018
3	Ribavirin (Virazole)FDA LinkGeneric 03/2023 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Cocaine (Cocaine HCl)IBA 04/2016 - 01/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 01/2022
2	InterferonsIBA 09/2016 - 01/2008
1	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 03/2023
1	SofosbuvirIBA 03/2023
1	W 12IBA 03/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2023
1	Ether (Diethyl Ether)IBA 01/2023
1	EndocannabinoidsIBA 01/2023
1	A-factor (Streptomyces)IBA 06/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	VaccinesIBA 09/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	insulin receptor-related receptor (IRR)IBA 01/2017
1	Opiate AlkaloidsIBA 04/2016
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2014
1	RNA (Ribonucleic Acid)IBA 03/2013
1	Hepatitis B e AntigensIBA 04/2011
1	Interleukin-2 (IL2)IBA 09/2007
1	InterleukinsIBA 09/2007
1	Antidepressive Agents (Antidepressants)IBA 01/2007
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2007
1	Hypnotics and Sedatives (Sedatives)IBA 01/2007

11	Therapeutics 03/2023 - 09/2007
4	Art Therapy 01/2016 - 12/2008
2	Condoms (Condom) 02/2015 - 04/2010
1	Retreatment 01/2024
1	Aftercare (After-Treatment) 03/2023
1	Tattooing 11/2021
1	Liver Transplantation 01/2020
1	Ambulatory Care (Outpatient Care) 01/2019
1	Palliative Care (Palliative Therapy) 09/2016
1	Opiate Substitution Treatment 02/2014
1	Highly Active Antiretroviral Therapy (HAART) 05/2007